Department of Pulmonary Diseases and Home Mechanical Ventilation, Maastricht University Medical Center+, Maastricht, The Netherlands.
Department of Pulmonary Diseases and Home Mechanical Ventilation, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Respiration. 2021;100(8):816-825. doi: 10.1159/000515453. Epub 2021 May 7.
Chronic hypercapnic respiratory failure induces considerable morbidity and mortality in patients with myotonic dystrophy type 1 (DM1). This study systematically reviews the effects of noninvasive home mechanical ventilation (HMV) on gas exchange, quality of life, survival, and compliance in DM1 patients.
A systematic Medline and Embase search was performed (January 1995 to January 2020). Records were screened for eligibility criteria, data were extracted from included studies, and risk of bias was assessed. We present findings mainly using a narrative synthesis.
Twenty-eight relevant full-text articles were screened for eligibility criteria. Nine studies were included. Randomized controlled trials were not found. Studies had either an observational (n = 8) or interventional (n = 1) design. In the pooled data analysis, HMV showed to improve mean oxygen saturation with 4.8% and decreased mean carbon dioxide values with 3 mm Hg. Compliance varied widely between studies, from no use to more than 12 h per day. Quality of life was not studied extensively, but some studies reported positive effects of HMV on symptoms of chronic respiratory failure. HMV may improve survival in DM1 patients with chronic hypercapnic respiratory failure.
This review shows that HMV can improve gas exchange and relieve symptoms with a possible survival benefit in DM1 patients with chronic hypercapnic respiratory failure. Future studies should focus on developing strategies to optimize the timing of HMV initiation and to promote compliance.
慢性高碳酸血症性呼吸衰竭会导致 1 型肌强直性营养不良(DM1)患者产生较高的发病率和死亡率。本研究系统地综述了无创家庭机械通气(HMV)对 DM1 患者气体交换、生活质量、生存率和顺应性的影响。
对 Medline 和 Embase 进行了系统检索(1995 年 1 月至 2020 年 1 月)。筛选合格标准的记录,从纳入的研究中提取数据,并评估偏倚风险。我们主要使用叙述性综合呈现研究结果。
对符合资格标准的 28 篇全文文章进行了筛选。纳入了 9 项研究。没有发现随机对照试验。研究设计为观察性(n=8)或干预性(n=1)。在汇总数据分析中,HMV 显示可将平均血氧饱和度提高 4.8%,将平均二氧化碳值降低 3mmHg。顺应性在研究之间差异很大,从无使用到每天超过 12 小时不等。生活质量没有得到广泛研究,但一些研究报告 HMV 对慢性呼吸衰竭症状有积极影响。HMV 可能改善慢性高碳酸血症性呼吸衰竭的 DM1 患者的生存率。
本综述表明,HMV 可以改善气体交换,缓解症状,并可能对慢性高碳酸血症性呼吸衰竭的 DM1 患者有生存获益。未来的研究应集中于制定策略,优化 HMV 启动时机,并提高顺应性。